Drugs / Platelet-Poor Plasma Gel
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT07306611 Comparator | Jun 2024 → Jun 2025 | postmenopausal atrophic vaginitis | AndreiaAntunes | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platelet-Poor Plasma Gel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07306611 ↗ |
| Route | Topical | “Activated platelet-poor plasma gel is applied topically to the vulvar area” NCT07306611 ↗ |